Treatment costsCAR-T Cell Therapy Cost

Cell-therapy pricing

CAR-T Cell Therapy Cost in Germany for International Patients

Understand why CAR-T treatment requires an individualized German hospital quotation and which clinical and logistical components can materially affect the total cost.

By Treat in Germany Editorial TeamSources reviewed: 2026-08-29Independent clinician review: not yet claimed
Short answer: A single generic CAR-T price is not a safe basis for medical-travel budgeting. The total episode can include eligibility assessment, leukapheresis, cell-product manufacturing, bridging treatment, lymphodepleting chemotherapy, infusion, prolonged inpatient monitoring and treatment of serious complications. Charité's international-patient process states that the hospital provides a cost estimate for the expected stay after specialist review and requests upfront payment before admission.

Why an individual hospital estimate comes first

For international self-paying patients, a useful German quotation is normally prepared only after the medical records have been reviewed and the responsible clinical team has defined the expected treatment. The estimate may require advance payment and is later reconciled against the services actually delivered.

  • Medical-record review
  • Defined clinical treatment plan
  • Written cost estimate
  • Advance payment when required
  • Monitoring of additional services
  • Final invoice after treatment

CAR-T is a multi-stage treatment episode

The cost cannot be understood as the infusion alone. The clinical pathway may span several weeks and can change if the disease progresses, bridging therapy is needed, manufacturing is delayed or complications require intensive treatment.

Components that can materially affect the total

A quotation should be read together with the treatment plan.

  • Eligibility diagnostics and pathology review
  • Leukapheresis
  • Cell-product manufacturing
  • Bridging therapy when required
  • Lymphodepleting chemotherapy
  • CAR-T infusion
  • Inpatient monitoring
  • Management of cytokine-release syndrome or neurological toxicity
  • Follow-up blood tests, imaging and specialist visits

Ask what happens if the planned pathway changes

International patients should ask how additional hospital days, intensive care, unexpected medicines or a change in eligibility are handled financially. A preliminary estimate cannot guarantee that the original total will equal the final invoice.

Budget for the required stay near the treatment center

CAR-T programs may require the patient to remain close to the specialist center after infusion. Accommodation and companion costs can therefore be substantial even when they sit outside the hospital invoice.

Official sources

Last source-reviewed 2026-08-29. Cost procedures and published service fees can change, so confirm current terms directly with the provider before transferring money or booking travel.

Pricing notice: Treat in Germany does not issue hospital quotations and does not guarantee a treatment price. Hospital-specific published fees on this site are labeled as examples and should not be interpreted as national averages.
Verified treatment centers

German centers documenting this treatment

These are not rankings or paid recommendations. Each center is included because its official website documents the relevant treatment or specialist program. Availability for an individual patient still requires medical review.

University Medical Center Freiburg CAR-T Program

Freiburg · Freiburg publishes a dedicated CAR-T treatment pathway within its hematology and oncology program and also provides an international-patient contact route.